HSGX Histogenics Corporation

1.85
+0.00  (0%)
Previous Close 1.85
Open 1.86
Price To book 5.87
Market Cap 41.01M
Shares 22,166,000
Volume 33,894
Short Ratio 2.45
Av. Daily Volume 62,791

SEC filingsSee all SEC filings

  1. 8-K - Current report 17930437
  2. 8-K - Current report 17909474
  3. CT ORDER - Confidential treatment order 17860514
  4. 8-K - Current report 17858896
  5. 10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)] 17858870

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 enrollment to be completed by end of 2Q 2017. Top-line data due mid 2018.
NeoCart
Cartilage defects in the knee